Stocks to sell

Novavax (NASDAQ:NVAX) was so close to hitting gold, but the delay in FDA approval for its Covid-19 vaccine has taken the life out of this stock, leaving a lot of investors wondering — what’s next? After reporting its first-quarter results, NVAX stock dipped 20% and hit $43. Despite making the right moves and filing for
0 Comments
Dogelon Mars (ELON-USD) is currently one of the most volatile assets you can own. The token has almost no utility or revenue generation to be a profitable asset in the long-term. For example, Ethereum (ETH-USD) has thousands of ERC20 tokens that pay fees to the Ethereum network. Thus, these tokens add utility and a source
0 Comments
With Twitter (NYSE:TWTR) and TWTR stock facing multiple, tough threats and possessing no major positive catalysts, I recommend that investors sell the shares. Overall, the biggest threat facing Twitter and its shares is the possibility that the takeover of the company — led by Tesla (NASDAQ:TSLA) CEO Elon Musk — will not close. Such an outcome
0 Comments
Aterian (NASDAQ:ATER) released its first-quarter report on Monday, in which it revealed an earnings miss of 52 cents per share and a revenue shortfall of $1.14 million. This really shouldn’t come as a surprise, and I believe ATER stock is headed for another downward spiral.  Much has been made of Aterian’s business model. However, I
0 Comments
Nio (NIO) offers Tesla (TSLA) luxury without the production volumes. The company has stiff competition within China, and those competitors are now exporting. Nio will likely remain small, and investors should demand a profit. Source: Robert Way / Shutterstock.com At this point in the game, investing in Nio (NYSE:NIO) stock means investing in the Chinese
0 Comments
Medical health services company Teladoc Health (NYSE:TDOC) has seen its prognosis go from bad to worse over the past month. TDOC stock had already plunged as part of the broader selloff in speculative technology companies. However, that selloff accelerated dramatically following Teladoc’s latest earnings report, which was a disappointment on almost all fronts. The terrible
0 Comments
With SoFi (NASDAQ:SOFI) likely to continue to be hurt by the Biden administration’s policies on student loans and the company still facing many other tough challenges, I am still recommending that investors sell SOFI stock. As Seeking Alpha columnist Business Quant explained in a recent column on SOFI stock, the moratoriums on student loan payments
0 Comments
Affirm (NASDAQ:AFRM) continues to fly multiple red flags, including a high valuation, very tough competition and a bottom line that may be deteriorating. Additionally, there are multiple signs that the Street is quite bearish on the shares. In light of all of these points, I continue to recommend investors sell AFRM stock. The trailing price-to-sales
0 Comments